About CIS Pharma Biomaterials
CIS Pharma has developed a platform of proprietary polymers, including a toolki, to create biomaterials specific to their application and site of use. The platform polymers are applicable in the fields of nanotechnology, diagnostics and biomedicine. Tissue regeneration, lab-on-a-chip assays and scaffolds releasing active agents are targeted applications. Novel polymer structures offer contact points for conjugation and delivery of therapeutics. The structures are adapted to fit the chemical and physical properties of the therapeutics and the site of delivery. Conjugated active compounds comprise small molecules as well as large protein-based drugs. Specific linker chemistry is applied to control the release kinetics of conjugated therapeutics.
Both the platform monomers as well as polymers show excellent biocompatibility, superior to commonly used building blocks in the implant industry. The safety of our building blocks has been demonstrated in cytotoxicity and genetoxicity models.